Sandra Almeida

Sandra Almeida

Assoc. Director, Medical Excellence and Innovation Lead KalVista Pharmaceuticals
Sandra Almeida

Previously at Janssen EMEA, leadership and digital transformation define my mandate, where I've played a central role in steering strategic plans for integrating evidence and communication. Our team's efforts in digital change initiatives and stakeholder relationship management have been pivotal in enhancing healthcare impact across diverse geographies. My tenure with Takeda reinforced a commitment to innovation, particularly through the integration of AI to revolutionize the patient journey. Collaborating with global teams, we pioneered algorithms for early diagnosis and navigated public health policies to emphasize personalized medicine. These experiences solidify my expertise in transforming medical evidence and strategy in a digital era.

Pharma Launch Excellence Summit Main Conference Day 2: Wednesday 3rd December

10:15 AM Morning Presentation/Case Study: Doing More with Less - Resourceful Launch Execution

Successful launches are rarely decided at launch. They are built years earlier, when evidence, access and stakeholder engagement are planned, often with limited resources. In this session, we explore how Medical Affairs can act as the “backstage” of launch excellence: shaping the value story, integrating evidence generation and dissemination, and preparing the market long before the first prescription. Drawing on real-world experience from multiple launches, we will discuss practical ways to prioritize when budgets are tight, leverage in-house skills, and use insights and omnichannel communication to focus effort where it truly matters. Participants will leave with a simple framework and concrete examples to help Medical teams work as one cross-functional engine, rather than in silos, and to demonstrate the impact of Medical on launch success.

Check out the incredible speaker line-up to see who will be joining Sandra.

Download The Latest Agenda